The p75^NTR metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells

By Nalbandian Angèle   Djakiew Daniel  

Clinical and Experimental Metastasis, Vol. 23, Iss. 2, 2006-04 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer

By Tahara Kouichirou  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3362-3369

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients

By Lomholt Anne Fog   Christensen Ib J.   Høyer-Hansen Gunilla   Nielsen Hans J.  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 805-811

Informa Healthcare

Access to resources Recommend Favorite

Tissue-Type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance

By Corte M.  

Breast Cancer Research and Treatment, Vol. 90, Iss. 1, 2005-03 ,pp. : 33-40

Springer Publishing Company

Access to resources Recommend Favorite

Neutrophil activator of matrix metalloproteinase-2 (NAM)

By Rollo Ellen   Hymowitz Michelle   Schmidt Cathleen   Montana Steve   Foda Hussein   Zucker Stanley  

Clinical and Experimental Metastasis, Vol. 23, Iss. 5-6, 2006-11 ,pp. : 259-268

Springer Publishing Company

Access to resources Recommend Favorite